Smith C M, Anderson S D
Department of Thoracic Medicine, Royal Prince Alfred Hospital, Camperdown, Australia.
J Allergy Clin Immunol. 1989 Nov;84(5 Pt 1):781-90. doi: 10.1016/0091-6749(89)90309-6.
The measurement of bronchial hyperresponsiveness with inhaled aerosols is now accepted as an objective measurement of the severity of asthma. The most commonly used agents administered as aerosols are methacholine and histamine, which are believed to cause airways to narrow by contracting bronchial smooth muscle via specific receptors. Patients with asthma may also have an attack provoked by inhaling aerosols that increase or decrease the osmolarity of the fluid lining the airways. There is evidence to suggest that a change in the osmolarity of the airways causes the release of mediators from inflammatory cells in the airways. Thus, inhalational challenge with nonisotonic aerosols, such as water and hyperosmolar saline, may be useful to assess bronchial hyperresponsiveness to endogenously released mediators. Described in this article are some of the techniques used to challenge with nonisotonic aerosols, and airway responses are discussed in relation to responses obtained with other bronchial provocation tests. The mechanisms whereby these aerosols cause airways to narrow are considered, and the clinical implications of identifying responsiveness to these aerosols are discussed. Specific recommendations are made with respect to equipment, technique, and choice of aerosol.
使用吸入气雾剂测量支气管高反应性现已被公认为是评估哮喘严重程度的一种客观方法。作为气雾剂使用的最常用药物是乙酰甲胆碱和组胺,它们被认为是通过特定受体使支气管平滑肌收缩从而导致气道变窄。哮喘患者吸入改变气道内衬液渗透压的气雾剂时也可能引发发作。有证据表明,气道渗透压的变化会导致气道内炎症细胞释放介质。因此,用非等渗气雾剂(如水和高渗盐水)进行吸入激发试验,可能有助于评估支气管对内源性释放介质的高反应性。本文介绍了一些使用非等渗气雾剂进行激发试验的技术,并结合其他支气管激发试验所获得的反应来讨论气道反应。文中考虑了这些气雾剂导致气道变窄的机制,并讨论了确定对这些气雾剂反应性的临床意义。针对设备、技术和气雾剂的选择给出了具体建议。